Our TB elimination strategy is based on ‘whole of the society’ and ‘whole of the government’ approach: JP Nadda
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Convergent action on AMR identified as an important area of intervention
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Science communication brings behavioural changes
The centre has initiated next generation sequencing (NGS) as a tool for undertaking studies on genomic epidemiology of pathogens
Subscribe To Our Newsletter & Stay Updated